Skip to main content

Table 1 Date on pneumocystis pneumonia during administrarion of infliximab

From: Increased dosage of infliximab is a potential cause of Pneumocystis carinii pneumonia

No.

Reference

Year

Sex

Age at diagnosis (years)

Crohn’s disease duration

IFX duration

Dose of IFX

Concomitant drug(s)

Medication

Clinical course

1

Seddik et al. [6]

2004

Male

29

ND

1 month

5 mg/kg

PSL + AZA

ST

2 weeks alive

2

Velayos et al. [7]

2004

Male

19

2 years

2 years 3 months

5 mg/kg

AZA

ST + PSL

2 weeks alive

3

Kaur et al. [8]

2004

Male

59

3 weeks

9 weeks

ND

PSL

ST + PM

1 month died

4

Stratakos et al. [9]

2005

Female

77

9 months

8 months

5 mg/kg

mPSL + AZA

ST

6 month alive

5

Itaba et al. [10]

2007

Female

57

21 years

5 weeks

5 mg/kg

PSL + AZA

ST + mPSL

4 month alive

6

金井 et al. [11]

2009

Male

69

44 years

4 weeks

5 mg/kg

5-ASA + PSL

ST + mPSL

6 month alive

7

Tshudy et al. [12]

2010

Male

8

6 years

15 months

5 mg/kg

None

ST

4 weeks alive

8

Present case

2014

Male

51

24 years

10 years

10 mg/kg

6-MP (0.15 g/day)

ST

1 year 5 month alive

  1. ST sulfamethoxazole/trimethoprim, PSL prednisolone, mPSL methylprednisolone, PM pentamidine, AZA azathioprine, 5-ASA mesalazine, 6-MP 6mercaptopurine, ND not described